Zobrazeno 1 - 10
of 70
pro vyhledávání: ''
Autor:
Ariana Pereira García, Christian Rolfo, Luis E. Raez, Andrés F. Cardona, Luis Lara-Mejía, Alejandro Aviles Salas, Enrique Caballé Pérez, Oscar Arrieta, Diego Díaz-García, Ixel Escamilla, Rafael Rosell
Publikováno v:
Repositorio U. El Bosque
Universidad El Bosque
instacron:Universidad El Bosque
Universidad El Bosque
instacron:Universidad El Bosque
Introduction Brain metastases (BM) are frequent among lung cancer patients, affecting prognosis and quality of life. The International Association for the Study of Lung Cancer (IASLC), American Thoracic Society (ATS) and European Respiratory Society
Efficacy of immune check-point inhibitors (ICPi) in large cell neuroendocrine tumors of lung (LCNEC)
Publikováno v:
Lung Cancer. 143:40-46
Objectives Little is known regarding the ICPi efficacy in LCNEC. We explored the efficacy and safety of ICPi in LCNEC and assessed its impact on OS. Materials and methods Thirty-seven consecutive patients with advanced LCNEC were selected from the Da
Autor:
Weiqiang Zhao, Mahmoud Abdel-Rasoul, Desmond M. D’Souza, David P. Carbone, Robert E. Merritt, Dan Jones, Peter J. Kneuertz, Terrance M. Williams, Konstantin Shilo
Publikováno v:
Lung Cancer. 143:60-66
This study aimed to evaluate the prognostic and potential therapeutic value of expanded molecular testing of resected early-stage lung ACA.We analyzed 324 patients who underwent lobectomy and lymphadenectomy for clinical Stage III lung ACA between 20
Publikováno v:
Lung Cancer. 142:13-19
Objectives This study is aimed to analyze the survival differences among patients with lung basaloid squamous cell carcinoma (BSCC), keratinizing squamous cell carcinoma (KSCC), and nonkeratinizing squamous cell carcinoma (NKSCC), and explore the pro
Autor:
Paul F. Pinsky, David S. Gierada
Publikováno v:
Quant Imaging Med Surg
Objective Non-calcified nodules (NCNs) associated with false positive low-dose CT (LDCT) lung cancer screens have been attributed to various causes. Some, however, may represent lung cancer precursors. An association of NCNs with long-term lung cance
Autor:
Davide Taietti, Sergio Harari, Sascia Pietro Servillo, Maurizio Zompatori, Matteo Incarbone, Giuseppe Pelosi, Francesco Nesa, Alberto Meroni, Nikolaos Papanikolaou
Publikováno v:
Lung Cancer. 137:43-47
Objectives Spread through air spaces (STAS) is a recently proposed invasion way of lung cancer, including neuroendocrine (NE) neoplasms. However, if this phenomenon is a real one or an artifact while manipulating lung specimens, it is still matter of
Publikováno v:
Lung Cancer. 137:123-128
Our study aimed to investigate the independent prognostic values of consolidation-to-tumor ratio (CTR) and tumor disappearance ratio (TDR) after adjustment for the conventional prognostic factors and the eighth edition clinical T category for patient
Autor:
Youngjoo Lee, Nak Jung Kwon, Sung-Ho Goh, Jae Hyun Jeon, Jin Ho Choi, Moon Soo Kim, Hanseong Roh, Geon Kook Lee, Hee Chul Yang, Ji Young Yun, Ji Youn Han, Jong Mog Lee
Publikováno v:
Lung Cancer. 136:15-22
Accumulating evidence reveals the association between the risk of never-smoker lung cancer and family history of cancer. However, the clinicogenomic effect of family history of cancer in never-smoker lung cancer remains unknown.We screened 3,241 lung
Autor:
Hironori Haga, Makoto Sonobe, Akihiro Ohsumi, Terumasa Sowa, Toyofumi F. Chen-Yoshikawa, Yojiro Yutaka, Akihiko Yoshizawa, Shinya Neri, Hiroshi Date, Masatsugu Hamaji, Toshi Menju, Toshihiko Sato, Daisuke Nakajima
Publikováno v:
Lung Cancer. 128:13-19
Microscopic vessel invasion (MVI) and visceral pleural invasion (VPI) have been recently reported as poor prognostic factors of non-small cell lung cancer. Epithelial-mesenchymal transition (EMT) and cancer stemness (CS) are known malignant phenotype
Autor:
Takashi Seto, Kazuki Takada, Mototsugu Shimokawa, Yoshihiko Maehara, Akira Haro, Atsushi Osoegawa, Yoshinao Oda, Tetsuzo Tagawa, Kenichi Kohashi
Publikováno v:
Lung Cancer. 128:26-32
Objectives Combination therapy with an inhibitor of indoleamine 2, 3-dioxygenase 1 (IDO1) and an agent targeting programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) is expected to be a novel and effective treatment option for variou